MedTrace Logo

Test of a Preventive Effect of a Deodorant Device Against Respiratory Infections

NCT00969800 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1469

Last updated 2010-02-04

No results posted yet for this study

Summary

This study is to test whether a chlorine dioxide gas-generating device, which releases a low concentration gas of chlorine dioxide in a sustained manner, can protect against respiratory infections in elderly individuals living in nursing homes. Such a device is used as a deodorant for normal domestic purposes. The investigators reasoned that the antiviral and antibacterial properties of chlorine dioxide might lead to a lowering in the incidence of respiratory infectious diseases. The study is designed as a randomized placebo-controlled double-blind crossover multicentre trial involving approximately 1500 subjects.

Conditions

  • Respiratory Infection

Interventions

DEVICE

Cleverin Gel

Chlorine dioxide gas concentration at a range of 0.005 to 0.03 ppm.

DEVICE

Inactive Cleverin Gel

Seemingly same chlorine dioxide gas-generating device, but no gas is generated.

Sponsors & Collaborators

  • Taiko Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Norio Ogata, MD, PhD · Taiko Pharmaceutical Co., Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-03-31
Completion
2010-04-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00969800 on ClinicalTrials.gov